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Introduction: There are limited data regarding associations between lipids and platelet aggregation (PA) in peripheral arterial disease (PAD) 
patients.
Methods: Pre randomization data in PAD patients (Ankle brachial index < 0.9, n =93), enrolled in the Effect of Lipid Modification after Intervention 
(ELIMIT) trial were analyzed. Aggregation was induced by a combined stimulation of collagen, fluid shear stress, and adenosine diphosphate (ADP) or 
epinephrine (Epi) using platelet function analyzer (PFA100) and optical aggregometry for 0.5mg/ml arachidonic acid (AA) and 10 μM ADP. Increased 
PA was defined as PFA100 Epi closure time <164 seconds, AA aggregation >30%, or ADP aggregation >70%. Adult treatment panel III guidelines 
based cutoffs for lipids in PAD were used to evaluate their associations with measures of PA.
Results (table):
Higher proportion of patients with elevated LDL-C and non-HDL-C (borderline significant) had increased PA with AA and Epi. Higher HDL-C levels were 
associated with increased PA with AA. Elevated triglyceride (TG) levels were associated with a borderline decrease in PA with AA.
Conclusion: LDL-C and non-HDL-C are associated with increased PA in PAD, potentially by increasing platelet membrane lipids (microdomains). 
HDL-C levels were also associated with enhanced PA with AA, suggesting that cholesterol by itself could have pro-aggregatory effect in PAD patients. 
This along with decrease PA with AA with elevated TGs was unexpected and needs further study. 
Lipid parameter
n (%) with PFA 100 
Epinephrine closure time 
<164 sec
p value for 
comparison
n (%) with AA 
aggregation 
>30%
p value for
comparison
n (%) with ADP 
aggregation > 70%
p value for
comparison
LDL-C < 100 mg/dl 7 (17)
0.04
5 (11)
0.01
26 (58)
0.34
LDL-C > 100 mg/dl 13 (37) 13 (33) 19 (48)
NonHDL-C* < 130 mg/dl 8 (20)
0.07
6 (13)
0.11
25 (56)
0.80
NonHDL-C* > 130 mg/dl 16 (37) 13 (27) 26 (53)
HDL-C< 40 mg/dl 13 (31)
0.62
5 (11)
0.02
27 (57)
0.53
HDL-C> 40 mg/dl 11 (26) 14 (30) 24 (51)
TG <150 mg/dl 13 (32)
0.53
13 (29)
0.05
26 (58)
0.51
TG >150 mg/dl 11 (26) 6 (12) 25 (51)
Table: Number (percentage) of patients with PAD with abnormal platelet aggregation across various lipid categories. LDL-C = low density 
lipoprotein cholesterol, Non HDL-C = Non High density Lipoprotein cholesterol, HDL-C = High density lipoprotein cholesterol, TG = triglycerides.
*Non HDL-C = total cholesterol minus HDL-C
